Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells

This publication has 51 references indexed in Scilit:

• Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor
  Molecular Immunology, 2008
• Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin’s lymphomas: a focus on FavId™
  Expert Opinion on Biological Therapy, 2005
• Mannoproteins fromCryptococcus neoformansPromote Dendritic Cell Maturation and Activation
  Infection and Immunity, 2005
• Clinical Outcome of Lymphoma Patients After Idiotype Vaccination Is Correlated With Humoral Immune Response and Immunoglobulin G Fc Receptor Genotype
  Journal of Clinical Oncology, 2004
• Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor
  Clinical Cancer Research, 2004
• Dual function of C-type lectin-like receptors in the immune system
  Current Opinion in Cell Biology, 2003
• Virus-like particle and DNA-based candidate AIDS vaccines
  Vaccine, 2003
• The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells
  European Journal of Immunology, 1997
• Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.
  The Journal of Experimental Medicine, 1995
• Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
  New England Journal of Medicine, 1982